US Patent Issued to New York Institute of Technology on Oct. 28 for "Method for ameliorating autism symptoms by pharmacological activation of the neurotensin receptor 1 (NTSR1)" (New York Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,757, issued on Oct. 28, was assigned to New York Institute of Technology (Old Westbury, N.Y.).

"Method for ameliorating autism symptoms by pharmacological activation of the neurotensin receptor 1 (NTSR1)" was invented by Gonzalo Hugo Otazu Aldana (Queens, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and formulations for treating autism with neurotensin R1 agonists without causing significant lethargy in a subject."

The patent was filed on Nov. 1, 2023, under Application No. 18/386,081.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=...